Cipla gets USFDA nod for contraceptive injection

Depo-Provera and its generic equivalents had US sales of around USD 159 million for the 12-month period ending November 2018, Cipla further said.

from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2Rk14xx
via IFTTT